Parkinson’s disease (PD) is a neurodegenerative disorder characterized by a dysregulation of cellular degradation system. An accumulation of misfolded proteins has been founded in the brains of parkinsonian patients, causing neuroinflammation and oxidative stress, and leading to a progressive neurodegeneration. Autophagy plays an important role in the progression of PD. In this chapter, we analyze the relationship of different types of autophagy (microautophagy, chaperone- mediated autophagy (CMA) and macroautophagy) with the oxidative stress and with several proteins involved in PD, showing deregulation of these degradative processes when these proteins are mutated. Also, we show a possible therapeutic alternative based on autophagy inducers that might be a potential drug for PD treatment.
CITATION STYLE
González-Polo, R. A., Gómez-Sánchez, R., Pizarro-Estrella, E., Yakhine-Diop, S. M. S., Rodríguez-Arribas, M., & Fuentes, J. M. (2015). Control of autophagy in parkinson’s disease. In Toxicity and Autophagy in Neurodegenerative Disorders (pp. 91–122). Springer International Publishing. https://doi.org/10.1007/978-3-319-13939-5_6
Mendeley helps you to discover research relevant for your work.